logologo
QuantliQuantli

Stoke Therapeutics Inc

STOK

NASDAQ

Biotechnology

$31.27

USD

-0.04 (-0.13%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $2.04B

Volume 495.1K

Price Target

$35.00$58.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $58.00 and a min estimate of $35.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$44.25

+$2.3 vs prior

Implied Upside

+41.5%

+7.2% vs prior

Analyst Covering

4

-2 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

40%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$2.25 Gap

Median $42.00 vs avg $44.25 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Keay Nakae

Chardan Capital

Buy

Maintained

1 week ago

Plus
Plus
Plus

Sumant Kulkarni

Canaccord Genuity

Buy

Maintained

1 week ago

Plus
Plus
Plus

Laura Chico

Wedbush

Buy

Maintained

1 week ago

Plus
Plus
Plus

Kevin Strang

Goldman Sachs

Buy

Initiated

4 weeks ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AGIO

Agios Pharmaceuticals Inc

$33.56

+0.3%

ADMA

ADMA Biologics Inc

$9.47

+0.6%

ZBIO

Zenas Biopharma Inc

$29.51

+1.1%

DMRA

Damora Therapeutics Inc

$31.04

+1.0%

TSHA

Taysha Gene Therapies Inc

$5.95

-0.7%

SRPT

Sarepta Therapeutics Inc

$18.10

-1.7%

PGEN

Precigen Inc

$6.10

-6.0%

VRDN

Viridian Therapeutics Inc

$22.08

+0.4%

GENB

Generate Biomedicines Inc

$15.64

+4.1%